These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

843 related articles for article (PubMed ID: 16840201)

  • 1. Consolidation therapy for adult acute myeloid leukemia: a systematic analysis according to evidence based medicine.
    Visani G; Olivieri A; Malagola M; Brunori M; Piccaluga PP; Capelli D; Pomponio G; Martinelli G; Isidori A; Sparaventi G; Leoni P
    Leuk Lymphoma; 2006 Jun; 47(6):1091-102. PubMed ID: 16840201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of cytogenetic classification and MRD status correlates with outcome of autologous versus allogeneic stem cell transplantation in adults with primary acute myeloid leukemia in first remission.
    Yao J; Zhang G; Liang C; Li G; Chen X; Ma Q; Zhai W; Yang D; He Y; Jiang E; Feng S; Han M
    Leuk Res; 2017 Apr; 55():97-104. PubMed ID: 28189799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients.
    Visani G; Bernasconi P; Boni M; Castoldi GL; Ciolli S; Clavio M; Cox MC; Cuneo A; Del Poeta G; Dini D; Falzetti D; Fanin R; Gobbi M; Isidori A; Leoni F; Liso V; Malagola M; Martinelli G; Mecucci C; Piccaluga PP; Petti MC; Rondelli R; Russo D; Sessarego M; Specchia G; Testoni N; Torelli G; Mandelli F; Tura S
    Leukemia; 2001 Jun; 15(6):903-9. PubMed ID: 11417475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of allo-SCT, auto-SCT and chemotherapy for the treatment of patients with low- or intermediate-risk acute myeloid leukemia: a network meta-analysis.
    Ye W; Wu X; Zhao R; Jin X; Li H; Qu Y; Ji J; Liu Z
    Stem Cell Res Ther; 2024 May; 15(1):153. PubMed ID: 38816870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial.
    Suciu S; Mandelli F; de Witte T; Zittoun R; Gallo E; Labar B; De Rosa G; Belhabri A; Giustolisi R; Delarue R; Liso V; Mirto S; Leone G; Bourhis JH; Fioritoni G; Jehn U; Amadori S; Fazi P; Hagemeijer A; Willemze R;
    Blood; 2003 Aug; 102(4):1232-40. PubMed ID: 12714526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic overview of chemotherapy effects in acute myeloid leukaemia.
    Kimby E; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):231-52. PubMed ID: 11441935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Autologous Stem Cell Transplantation versus Haploidentical Donor Stem Cell Transplantation for Favorable- and Intermediate-Risk Acute Myeloid Leukemia Patients in First Complete Remission.
    Chen J; Yang L; Fan Y; Xu Y; Han Y; Tang X; Qiu H; Fu C; Miao M; Chen F; Wu D
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):779-788. PubMed ID: 29289758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Measurable Residual Disease in Patients With Intermediate-Risk Acute Myeloid Leukemia and First Remission, Treatment, and Outcomes.
    Yu S; Fan Z; Ma L; Wang Y; Huang F; Zhang Q; Huang J; Wang S; Xu N; Xuan L; Xiong M; Han L; Sun Z; Zhang H; Liu H; Yu G; Shi P; Xu J; Wu M; Guo Z; Xiong Y; Duan C; Sun J; Liu Q; Zhang Y
    JAMA Netw Open; 2021 Jul; 4(7):e2115991. PubMed ID: 34232303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey.
    Lazzarotto D; Candoni A; Filì C; Forghieri F; Pagano L; Busca A; Spinosa G; Zannier ME; Simeone E; Isola M; Borlenghi E; Melillo L; Mosna F; Lessi F; Fanin R
    Leuk Res; 2017 Feb; 53():74-81. PubMed ID: 28056398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.
    Koreth J; Schlenk R; Kopecky KJ; Honda S; Sierra J; Djulbegovic BJ; Wadleigh M; DeAngelo DJ; Stone RM; Sakamaki H; Appelbaum FR; Döhner H; Antin JH; Soiffer RJ; Cutler C
    JAMA; 2009 Jun; 301(22):2349-61. PubMed ID: 19509382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia.
    Candoni A; De Marchi F; Zanini F; Zannier ME; Simeone E; Toffoletti E; Chiarvesio A; Cerno M; Filì C; Patriarca F; Fanin R
    Exp Hematol; 2017 May; 49():25-33. PubMed ID: 28159598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review on allogeneic stem cell transplantation for newly diagnosed pediatric acute myeloid leukemia.
    Niewerth D; Creutzig U; Bierings MB; Kaspers GJ
    Blood; 2010 Sep; 116(13):2205-14. PubMed ID: 20538803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review.
    Ashfaq K; Yahaya I; Hyde C; Andronis L; Barton P; Bayliss S; Chen YF
    Health Technol Assess; 2010 Dec; 14(54):iii-iv, ix-xi, 1-141. PubMed ID: 21138675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
    Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R
    Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-intensive therapy for adult acute lymphoblastic leukemia.
    Finiewicz KJ; Larson RA
    Semin Oncol; 1999 Feb; 26(1):6-20. PubMed ID: 10073558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant.
    Motabi IH; Ghobadi A; Liu J; Schroeder M; Abboud CN; Cashen AF; Stockler-Goldstein KE; Uy GL; Vij R; Westervelt P; DiPersio JF
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1324-1329. PubMed ID: 27026249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients.
    Visani G; Lemoli RM; Isidori A; Piccaluga PP; Martinelli G; Malagola M; Gugliotta L; Bonini A; Bonifazi F; Motta MR; Rizzi S; Castellani S; Tura S
    Bone Marrow Transplant; 2001 Apr; 27(8):829-35. PubMed ID: 11477440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic assessment of measurable residual disease in favorable-risk acute myeloid leukemia in first remission, treatment, and outcomes.
    Yu S; Lin T; Nie D; Zhang Y; Sun Z; Zhang Q; Wang C; Xiong M; Fan Z; Huang F; Xu N; Liu H; Yu G; Zhang H; Shi P; Xu J; Xuan L; Guo Z; Wu M; Han L; Xiong Y; Sun J; Wang Y; Liu Q
    Blood Cancer J; 2021 Dec; 11(12):195. PubMed ID: 34873148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto-SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM-TC.
    Chevallier P; Labopin M; Socie G; Rubio MT; Blaise D; Vigouroux S; Huynh A; Michallet M; Bay JO; Maury S; Yakoub-Agha I; Fegueux N; Deconinck E; Contentin N; Maillard N; Bulabois CE; Francois S; Oumedaly R; Raus N; Mohty M
    Eur J Haematol; 2015 May; 94(5):449-55. PubMed ID: 25238651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.